Efficacy and Safety of Upadacitinib in TNFi-IR Patients with Rheumatoid Arthritis from Three Phase 3 Clinical Trials

被引：0

作者：

Fleischmann, Roy ^{[1
,2
]}

Bessette, Louis ^{[3
]}

Sparks, Jeffrey ^{[4
,5
]}

Hall, Stephen ^{[6
]}

Jain, Manish ^{[7
]}

Kakehasi, Adriana ^{[8
]}

Song, Yanna ^{[9
]}

Meerwein, Sebastian ^{[10
]}

DeMasi, Ryan ^{[9
]}

Suboticki, Jessica ^{[11
]}

Rubbert-Roth, Andrea ^{[12
]}

机构：

[1] Univ Texas South Western Med Ctr, Dallas, TX USA

[2] Metroplex Clin Res Ctr, Dallas, TX USA

[3] Ctr Ostoporose & Rhumatol Quebec, Quebec City, PQ, Canada

[4] Brigham & Womens Hosp, Boston, MA USA

[5] Harvard Med Sch, Boston, MA USA

[6] Emeritus Res & Monash Univ, Melbourne, Australia

[7] Great Lakes Clin Trials, Chicago, IL USA

[8] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil

[9] AbbVie Inc, N Chicago, IL USA

[10] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany

[11] AbbVie Inc, Mettawa, IL USA

[12] Cantonal Clin St Gallen, Div Rheumatol, St Gallen, Switzerland

来源：

ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0282

引用

页码：541 / 543

页数：3

共 50 条

[31] Pharmacokinetics of Upadacitinib With the Clinical Regimens of the Extended-Release Formulation Utilized in Rheumatoid Arthritis Phase 3 Trials
Mohamed, Mohamed-Eslam F.
Zeng, Jiewei
Marroum, Patrick J.
Song, In-Ho
Othman, Ahmed A.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (02): : 208 - 216
[32] THE ASSOCIATION BETWEEN PATIENT REPORTED OUTCOMES AND CLINICAL MEASURES AMONG RHEUMATOID ARTHRITIS PATIENTS: ANALYSES USING PHASE 3 CLINICAL TRIALS OF UPADACITINIB
Strand, Vibeke
Damjanov, Nemanja
Scoville, Craig
Tundia, Namita
Camp, Heidi
Chen, Kun
Suboticki, Jessica L.
van Vollenhoven, Ronald
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S54 - S54
[33] Safety Profile of Upadacitinib up to 3 Years of Exposure in Patients with Rheumatoid Arthritis
Cohen, Stanley
Van Vollenhoven, Ronald F.
Curtis, Jeffrey
Calabrese, Leonard
Zerbini, Cristiano A. F.
Tanaka, Yoshiya
Bessette, Louis
Schlacher, Casey
Shaw, Tim
Liu, John
Enejosa, Jeffrey
Song, Yanna
Burmester, Gerd
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[34] SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Cohen, S. B.
Van Vollenhoven, R.
Curtis, J. R.
Calabrese, L.
Zerbini, C.
Tanaka, Y.
Bessette, L.
Schlacher, C.
Shaw, T.
Liu, J.
Enejosa, J. J.
Song, Y.
Burmester, G. R.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 315 - 316
[35] Efficacy and Safety of Switching from Adalimumab to Baricitinib: Phase 3 Data in Patients with Rheumatoid Arthritis
Taylor, Peter C.
Keystone, Edward
Ortmann, Robert
Issa, Maher
Xie, Li
Muram, David
Bradley, John D.
de Bono, Stephanie
Rooney, Terence
Tanaka, Yoshiya
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[36] Efficacy and Safety of Sarilumab in Subgroups of Patients with Rheumatoid Arthritis from 2 Phase 3 Studies
Genovese, Mark C.
Fleischmann, Roy
Mangan, Erin
van Adelsberg, Janet
Iglesias-Rodriguez, Melitza
Dukovic, Deborah
Fan, Chunpeng
Huizinga, Tom W. J.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[37] Efficacy and Safety of Switching from Adalimumab to Baricitinib: Phase 3 Data in Patients with Rheumatoid Arthritis
Taylor, Peter
Keystone, Edward
Ortmann, Robert
Issa, Maher
Xie, Li
Muram, David
Bradley, John
de Bono, Stephanie
Rooney, Terence
Tanaka, Yoshiya
Faraawi, Rafat
JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 890 - 891
[38] EFFICACY AND SAFETY OF SARILUMAB IN SUBGROUPS OF PATIENTS WITH RHEUMATOID ARTHRITIS FROM 2 PHASE 3 STUDIES
Genovese, Mark C.
Fleischmann, Roy
Mangan, Erin K.
van Adelsberg, Janet
Iglesias-Rodriguez, Melitza
Fan, Chunpeng
Huizinga, Tom W.
RHEUMATOLOGY, 2017, 56 : 137 - 138
[39] Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
Baraliakos, Xenofon
Ranza, Roberto
Ostor, Andrew
Ciccia, Francesco
Coates, Laura C.
Rednic, Simona
Walsh, Jessica A.
Douglas, Kevin
Gao, Tianming
Kato, Koji
Song, In-Ho
Ganz, Fabiana
Deodhar, Atul
ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
[40] Effect of Filgotinib on Pain in Patients with Rheumatoid Arthritis: Results from Phase 3 Clinical Trials
Taylor, Peter
Kavanaugh, Arthur
Nash, Peter
Pope, Janet
Bartok, Beatrix
Hasegawa, Ken
Rao, Shangbang
Strengholt, Sander
Westhovens, Rene
ARTHRITIS & RHEUMATOLOGY, 2020, 72

← 1 2 3 4 5 →